Recent advancements in liquid biopsies have demonstrated the potential of cfDNA as a universal, minimally invasive sample type in cancer prognosis, diagnosis, and prenatal testing 1. In parallel, the ...
In recent years, liquid biopsy approaches have emerged as powerful tools in oncology, enabling non‑invasive, real‑time insights into tumor dynamics. Among these technologies, droplet digital PCR ...
MOUNTAIN VIEW, Calif., Jan. 28, 2015 /PRNewswire/ -- Based on its recent analysis of the digital PCR (dPCR) market, Frost & Sullivan recognizes Bio-Rad Laboratories, Inc. with the 2014 North American ...
HERCULES, Calif. -- October 30, 2018 -- A recent study published online in the Journal of Molecular Diagnostics demonstrated that Droplet Digital PCR (ddPCR) technology can be used to detect mutations ...
insights from industryChris Forsdyke, Martin LarkeFrancesca Manni, Chelsea PratthVIVO In this interview, Meredith Landry (Managing Editor, Citeline) speaks with Chris Forsdyke (Head of Laboratory ...
Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Download Brochure Accurate viral vector characterization in ...
Precise and rapid mutation detection is critical to cancer research. However, multiplexing cancer mutation detection is challenging due to the need to discriminate multiple sets of highly similar ...
Standardization is needed in CAR-T cell therapy development due to its inherent complexity. Chimeric antigen receptor (CAR)-T cells have already changed how certain cancers are treated. As of February ...
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the recent launch of the Vericheck ddPCR™ Replication ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results